addiction
What Does Dr. Julian Somers Actually Believe? – Cannabis | Weed | Marijuana
Published
2 years agoon
By
admin
What does Dr. Julian Somers actually believe?
Dr. Julian Somers is a researcher and professor in the mental health and addiction field in British Columbia, Canada. He is currently a professor at Simon Fraser University and serves as the Research Director of the Mental Health and Addictions Research Program.
In addition to his research, Julian has received numerous awards and recognitions for his contributions to the field of mental health, including the Canadian Institutes of Health Research (CIHR) Applied Public Health Chair in Urban Health, the Michael Smith Foundation for Health Research Scholar Award, and the Canadian Association for Health Services and Policy Research’s Best Paper Award.
But recently, because of his critiques of government policy and established “safe supply” narratives, he’s some “right-winger” retweeted by – trigger warning – Jordan Peterson and Pierre Poilievre.
Of course, as is usually the case, the reality is more nuanced. I caught up with Julian the other day via a Zoom call. I wanted to know: what does Dr. Julian Somers actually believe?
Do his critics have a point?
What Does Dr. Julian Somers Actually Believe?
So what does Julian Somers actually believe? In a nutshell, he believes the same thing Portugal said when they decriminalized drugs: “There is no such thing as addiction treatment.”
But what does that mean?
“They’re not saying overcoming addiction means not using drugs anymore,” says Julian. “They say overcoming addiction means being socially reintegrated.”
And indeed, that is the core of what Dr. Julian Somers actually believes. And that’s based on decades of extensive research.
How to Solve Addictive Behaviours
Social integration is when an individual feels connected to or is involved with their community. This can be as simple as meaningful conversations with friends, participating in social events, and contributing to local activities.
The idea is that if you build relationships with others, you can create a sense of belonging. Human beings are, after all, social animals. It’s not surprising that research suggests social integration enhances one’s sense of purpose and overall quality of life.
And for many researchers, from experts like Dr. Julian Somers to amateurs like myself, the evidence suggests “addictive behaviour” stems from this lack of purpose and belonging.
“Social integration is very close to what it would mean to have good mental health,” says Julian. “It means you have a job, a place to live, you’re part of a community. You feel good about other people and other people feel good about you.”
What does Dr. Julian Somers actually believe? That addictive behaviour is a mental health issue. That fixing Vancouver‘s Downtown Eastside means addressing the demand for drugs, not the supply.
“If there’s one thing we should have learned from the drug war,” says Julian, “Is that focusing on supply is a wasted effort.” Instead, “all our emphasis should have been on demand. On what’s up with the mental health of people in our population.”
Reasonable positions. And yet, “when I raise that, in one way or another, I am crucified.”
What Does Dr. Julian Somers Actually Believe? The Research
Why is Julian Somers criticized for his research? Take safe supply and Indigenous communities. He said:
“It seems obvious to me from all the available evidence right now that it would not help those communities to provide them with greater access to addictive drugs. It would help them most to support their growth of things they’re asking for: autonomy, resources, the ability to make decisions.”
Rat Park
This isn’t a controversial statement. Since the 1970s and 80s, researchers have known about “Rat Park.” Conducted by Canadian psychologist Bruce K. Alexander and his colleagues at Simon Fraser University, the studies challenged the prevailing narratives, which held that drug addiction was primarily a result of the pharmacology of the drug themselves.
The researchers set up two environments, a standard laboratory cage with access to only water and cocaine; and the other “Rat Park” full of toys, food, and other rats to socialize with, as well as cocaine. The researchers found the rats in Rat Park were less likely to become addicted to cocaine.
Brain Disease Model is Junk
Of course, rats aren’t people. But the general idea that social and environmental factors play a significant role in addiction is supported by numerous other studies. Somers references the number of American soldiers that used heroin in Vietnam. When they returned after the war, fewer than 5% continued using.
And there’s neuroscientist Mark Lewis’ research on brain imaging and the brain disease model of addiction. Mark’s research highlights the importance of environmental factors in addictive behaviour. He argued that addiction is not solely the result of brain changes but influenced by social and cultural factors. He also suggested social isolation and stress increase the risk of addiction.
Who Are Julian Somers’ Critics?
This Press Progress article demonstrates the mentality of the people attacking Julian Somers’ position. It posits that Somers and others are in it for the money.
At no point does it grapple with Julian’s ideas but parrots the open letter that his work criticizing safe supply was “critically low quality.”
“It’s a reinvention of ad hominem attacks,” says Julian, recalling a professor of his many years ago. He taught that when your critics shift the discourse from the ideas to the person making the ideas, you can smile. Because you know they’ve got nothing.
And this is likely the case here. The criticisms that Somers and others like him are only in it for the money are either deeply ironic or blatantly hypocritical.
In his research, Julian and his team have found that “almost all the papers in which authors had been advocating for so-called safe supply, were based in B.C.. They were people who did not have backgrounds in addiction, they came from an HIV centre. And they seem to have simply rolled out a business model that had worked in HIV. Which is obviously, very pharmaceutical.”
Pharmaceutical public-private partnerships are the name of the game.
“They seem to be using the same business model, partnerships with industry, to launch a presence in the addiction field… Their work was conspicuously pharma intensive.”
“And yet, in their documents, in their peer-reviewed publications, not one of them mentions the fact that people need housing, people need help getting jobs. People need help addressing their mental illnesses. Instead they say, we need immediately safe supply. In fact, it goes further. We need safe supply across North America.”
And why is this? Julian Somers believes this might be a follow the money story.
What Does Dr. Julian Somers Actually Believe? Follow the Money
Julian imagines a scenario that isn’t out of the realm of possibility. A conversation like this has undoubtedly happened more than once.
Somewhere in a New York office, suits are reeling from the oxy scandal. One of them is thinking of getting into diet pills or maybe vitamins. But another suit persuades him otherwise. “There’s this group out in B.C.,” he says, and they’ve figured out how to sell not only opioid compounds but stimulants and benzos.
“They’re calling it safe supply.”
The B.C. government is promising is get Wall Street’s product out front of the Nicaraguans and Colombians. It’s a new era of the drug war.
“It’s outrageous how it’s happened in a ten year period,” says Julian. “Along the way, there are people who are supporting their agenda and I think it’s conspicuously physicians.”
Physicians know very little about addiction. It’s a small part of med school; when it’s taught, it’s the brain-disease model. So doctors approach addictive behaviours as if it were a diabetes diagnosis.
What Does Dr. Julian Somers Actually Believe?
Julian Somers believes that if the country could have a mature conversation about drugs and addictive behaviour and take the necessary steps to create a population with better mental health, we would be “very close to having heroin available for purchase.”
The fact is, says Julian: “Most people who have addictions at one point, don’t have them later and they don’t all die.”
Brain imaging does not support the brain disease model of addiction. “What [Mark Lewis’ research] has pointed out,” says Julian, “is that the changes that occur before, during, and after addiction, are consistent with our understanding of how the brain reflects learning.”
“It’s actually tremendously inspiring, optimistic knowledge,” says Julian. “We are capable of changing!” And that’s what Julian Somers actually believes.
That the brain disease model of addiction is “vacuous and offensive” since it creates a segregation between rich and poor treatment.
While the rich are sent to places like the Betty Ford Center to work on their mental health, the poor are kept isolated and fed pharmaceuticals.
“It’s like two different worlds. And if you’re a physician, on some level, you know this,” says Julian.
So the question remains: what are his critics’ excuses? Especially the left-wing populists who claim to work and fight for the poor, oppressed, and helpless.
Don’t they know “safe supply” lines the pockets of corporate pharma without addressing the mental health issues of those suffering from addictive behaviours?
You may like
-
Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?
-
Hemp and the New Senate Farm Bill
-
The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?
-
Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants
-
Find LivWell in Colorado
-
Find Verilife in Massachusetts
addiction
Can Psychedelics Treat Addiction and Alcoholism?
Published
2 months agoon
September 13, 2024By
admin
Psychedelics, once associated primarily with counterculture and recreational drug use, are now being seriously studied for their therapeutic potential in treating drug addiction and alcoholism. Recent research has shown that substances like psilocybin, LSD, and ayahuasca may have profound benefits for individuals struggling with Alcohol Use Disorder (AUD) and substance use disorders (SUD). These compounds are being reconsidered not only for their ability to induce altered states of consciousness but also for their potential to address addictive behaviors and psychological trauma at the root of addiction.
Psilocybin’s Efficacy in Treating Alcohol Use Disorder
One groundbreaking study, conducted at New York University and Johns Hopkins University, demonstrated the potential of psilocybin in treating Alcohol Use Disorder (AUD). The researchers focused on individuals with severe AUD, administering two doses of psilocybin in conjunction with psychotherapy. The results were notable: participants reported a 50% reduction in heavy drinking days over an eight-month period, with some maintaining abstinence from alcohol even a year later.
The trial followed a double-blind, randomized approach and found that the therapeutic effects of psilocybin were superior to those observed with placebo treatments. Dr. Michael Bogenschutz, a lead researcher in the study, emphasized the importance of the psychedelic experience itself in breaking the cycle of addiction. Psilocybin appears to help patients break through entrenched mental patterns, often revealing deeper emotional connections and realizations that drive more meaningful behavior change.
How Psychedelics Influence the Brain to Combat Addiction
The mechanism behind the efficacy of psychedelics in treating addiction is thought to involve neuroplasticity, or the brain’s ability to reorganize and form new connections. By interacting with serotonin 2A receptors, particularly in the prefrontal cortex and default mode network, psychedelics can enable profound shifts in perception and cognition. These altered states of consciousness allow individuals to confront underlying psychological issues, such as trauma or negative emotional patterns, which are often at the core of addictive behaviors.
Many individuals undergoing psychedelic-assisted therapy report experiencing a “reset” of their mental state, facilitating a more open mindset that helps them engage with therapy in a deeper, more effective way. This contrasts with traditional addiction treatments, such as methadone or buprenorphine, which primarily manage withdrawal symptoms but do not address the psychological components of addiction.
LSD and Its Potential in Addiction Treatment
LSD (lysergic acid diethylamide) has also shown promise in treating addiction, particularly alcoholism. Early studies from the 1950s to the 1970s suggested that LSD might help reduce alcohol dependency, but interest in this line of research waned due to regulatory crackdowns on psychedelic research. However, more recent studies have reignited interest in LSD’s therapeutic potential.
A meta-analysis published in the Journal of Psychopharmacology reviewed data from six trials involving over 500 patients. It concluded that a single high dose of LSD, administered in a therapeutic setting, was associated with a significant reduction in alcohol consumption. The study found that LSD’s psychedelic effects could lead to lasting changes in personality traits, such as openness and emotional resilience, which are crucial for overcoming addiction.
Ayahuasca and Addiction Recovery
Ayahuasca, a traditional Amazonian brew containing DMT (dimethyltryptamine) and MAO inhibitors, has been the focus of recent studies examining its potential to treat addiction. Researchers have found that ayahuasca’s intense psychoactive properties, combined with its ability to facilitate introspection and emotional healing, may help individuals overcome opioid and stimulant addiction. A study published in Frontiers in Pharmacology noted that ayahuasca led to significant improvements in mental health and reductions in addictive behaviors.
Ayahuasca ceremonies, often conducted in a spiritual context, have been shown to promote healing through vivid and sometimes challenging visions. Participants often report gaining insights into the underlying causes of their addiction, leading to long-lasting psychological benefits.
Challenges in Psychedelic-Assisted Therapy
While the results of these studies are promising, the use of psychedelics in treating addiction is not without challenges. For one, the psychedelic experience itself can be unpredictable, and not all patients experience the profound mystical or emotional breakthroughs associated with positive outcomes. The effectiveness of psychedelic-assisted therapy appears to be linked to the quality of the therapeutic environment and the expertise of the facilitators, meaning that careful preparation and integration are key to success.
Moreover, while psychedelics like psilocybin and LSD do not appear to be physically addictive, their use must still be carefully regulated to prevent potential psychological risks, such as hallucinations, anxiety, or psychotic episodes in vulnerable individuals. Current research emphasizes the need for controlled settings where trained therapists can guide patients through their psychedelic experiences.
Ongoing Research and Future Directions
Given the promising early results, psychedelic research is entering a new phase, with larger clinical trials currently underway. The National Institutes of Health (NIH) recently allocated $2.4 million to explore the use of psychedelics in treating methamphetamine addiction, further solidifying the role of psychedelics in addiction therapy. Similarly, ongoing studies are looking into psilocybin’s potential to treat opioid addiction and cocaine dependence, conditions that have been notoriously difficult to treat with conventional methods.
As research progresses, it is likely that psilocybin, LSD, and other psychedelics will become more widely recognized as effective tools for addiction treatment. While more research is needed to fine-tune these therapies and better understand their long-term effects, early indications are that psychedelics could revolutionize addiction and alcoholism treatments in the coming decades.
Conclusion
Psychedelics like psilocybin, LSD, and ayahuasca are emerging as potential breakthrough therapies for treating drug addiction and alcoholism. By promoting neuroplasticity and addressing the psychological roots of addiction, these substances offer an alternative to traditional addiction treatments, which often focus on managing symptoms rather than curing the disease. With ongoing research and increasing clinical trials, psychedelic-assisted therapy may become an essential tool in the fight against substance use disorders, offering hope to millions of people who struggle with addiction, such as alcoholism.
Sources
Johns Hopkins Medicine: Psychedelics in Addiction Treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry
National Institutes of Health (NIH) Research on Psychedelics
Frontiers in Pharmacology: Ayahuasca for Addiction Recovery
JAMA Otolaryngology – Head & Neck Surgery
Related
addiction
The Evolving Opioid Crisis in Europe: Heroin and Synthetic Threats
Published
2 months agoon
September 12, 2024By
admin
The opioid crisis in Europe is growing in complexity, with heroin continuing to dominate the market while synthetic opioids, such as fentanyl and its analogs, emerge as potent new threats. The 2024 EU Drug Markets Report, released by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol, provides a comprehensive analysis of the heroin and synthetic opioid market, detailing the health risks, evolving trafficking routes, and potential future challenges.
Heroin in Decline? Why Synthetic Opioids Pose a New Threat in Europe
Heroin’s Ongoing Impact in Europe
Heroin remains the most commonly used illicit opioid in Europe, with an estimated 1 million high-risk opioid users. The European heroin market is valued at over €5.2 billion annually, indicating the persistent demand for this drug. In 2021, EU countries seized 9.5 tonnes of heroin, the largest quantity in 20 years. These figures underscore the strong presence of heroin in Europe, despite the introduction of harm reduction programs aimed at curbing opioid use.
The health consequences of heroin use are severe. In 2021, opioids were responsible for three-quarters of Europe’s 6,000 drug-related overdose deaths, with heroin being a leading factor. Long-term users are aging, adding complexity to public health strategies, as older opioid users present with more chronic health problems.
Afghanistan’s Opium Ban: Future Implications for Heroin Supply
Nearly all heroin consumed in Europe is derived from opium produced in Afghanistan. However, Afghanistan’s opium production has seen a dramatic decline following the Taliban’s 2022 ban on poppy cultivation, which led to a 95% reduction in production by 2023. While the immediate impact on heroin availability in Europe has been minimal, the report warns that a sustained ban could lead to future heroin shortages. Such shortages could open the door for synthetic opioids to dominate the market.
The decline in Afghan opium cultivation from 233,000 hectares in 2022 to just 10,800 hectares in 2023 has raised concerns about the future of heroin availability in Europe. Should the Taliban continue to enforce the ban, experts believe the resulting heroin scarcity could increase the use of more potent and dangerous synthetic opioids, exacerbating the public health crisis.
The Rise of Synthetic Opioids: Fentanyl and its Analogues
Synthetic opioids, such as fentanyl, are becoming more prevalent in the European drug market. These substances are far more potent than heroin, and even small doses can lead to fatal overdoses. The 2024 report highlights how these synthetic opioids are contributing to a growing number of overdose deaths and hospital emergencies across Europe. In countries such as Estonia and Sweden, fentanyl is responsible for a significant proportion of drug-related deaths.
Fentanyl analogs are particularly concerning because they can be mixed with other drugs like heroin or cocaine, often without the user’s knowledge. The increasing presence of these synthetic opioids is a major public health concern, as traditional harm reduction measures, such as naloxone distribution and needle exchange programs, are less effective against these more potent substances.
Changing Trafficking Routes and Criminal Networks
Traffickers are increasingly adapting their methods in response to heightened enforcement measures and geopolitical developments. The traditional Balkan route, which brings heroin through Turkey and Bulgaria into Europe, has seen increased enforcement and stricter border controls, prompting traffickers to shift towards alternative routes.
The Southern route is becoming more prominent, with significant heroin shipments passing through Iran and Pakistan before reaching Europe via major seaports. The United Arab Emirates (UAE) has emerged as a key transshipment hub for heroin, providing both logistical support and avenues for money laundering. Meanwhile, the ongoing Russia-Ukraine war has prompted criminal networks to modify their trafficking routes, further complicating law enforcement efforts.
Public Health and Harm Reduction Efforts
Harm reduction strategies have had some success in mitigating the impact of opioid use in Europe. Programs such as opioid substitution therapy (OST) and needle exchange have helped reduce the number of new users injecting heroin, thereby lowering the risks of HIV and hepatitis C transmission. However, the growing prevalence of synthetic opioids poses new challenges. These potent drugs often require stronger overdose prevention measures, such as fentanyl test strips and more widespread access to naloxone, an opioid antagonist used to reverse overdoses.
Additionally, the report notes the importance of expanding data collection and improving early warning systems to monitor emerging trends in opioid use and trafficking. These systems allow public health authorities and law enforcement to respond more quickly to new synthetic opioids entering the market.
Challenges in Treating Opioid Addiction
Treatment for opioid addiction, particularly heroin, is evolving. Europe’s aging population of opioid users presents new challenges, as older users are more likely to have complex medical conditions. Many long-term users require not just drug treatment but also social support and healthcare for chronic conditions related to long-term substance use. Furthermore, gender-specific issues are emerging, as women who use opioids face more barriers to accessing treatment and are more likely to present with co-occurring psychological or social issues.
Conclusion
The opioid crisis in Europe is evolving, with heroin still posing a significant threat to public health, while synthetic opioids like fentanyl are emerging as an even more dangerous force. The reduction in Afghan opium production and the shifting trafficking routes complicate the landscape further. To tackle this complex issue, Europe must continue to invest in harm reduction, international cooperation, and early warning systems to prevent more overdose deaths and manage the changing face of the opioid market. Without a coordinated response, Europe risks facing an even more devastating public health crisis in the coming years.
Related
The fact that some people are eating dogs and cats is a highly sensitive topic that crosses cultural, social, and ethical boundaries. In many regions, these animals are consumed due to cultural traditions and necessity, while in other cases, drug-induced behavior may lead individuals to engage in extreme or unusual dietary practices. This article aims to explore the distinction between cultural norms and the desperate, erratic behaviors driven by substance abuse, focusing on the need for cultural sensitivity while addressing harmful behavior.
When Culture Meets Addiction: Who Is Eating Dogs and Cats?
Cultural Practices and the Consumption of Non-Traditional Animals
In some parts of Asia and Africa, the phenomena of eating dogs and cats has historical roots that are tied to both cultural traditions and the availability of resources. In these regions, the eating of non-traditional animals is a normalized practice and is not connected to drug-fueled behavior.
- Cultural Normalcy: In regions such as South Korea, China, and Vietnam, dogs have historically been consumed as part of traditional cuisines. This practice is not driven by addiction or desperation but by cultural norms that view these animals as a food source rather than pets.
- Food Scarcity: In some communities, especially in impoverished or rural areas, consuming non-traditional animals like dogs or cats is a practical response to food scarcity. The decision to eat these animals is based on survival rather than personal preference or altered judgment.
Drug-Induced Dietary Choices: When Addiction Leads to Extreme Behaviors
In contrast to cultural practices, there are cases where individuals under the influence of drugs engage in extreme or bizarre behaviors, such as eating dogs and cats… This behavior is driven by impaired judgment, psychosis, or desperation caused by addiction, and often occurs in isolated or marginalized communities.
- Methamphetamine and Erratic Behavior: Meth users are known to exhibit extreme and irrational behaviors, including eating animals they wouldn’t normally consider food. Meth-induced psychosis can blur the lines between reality and hallucination, leading to bizarre dietary choices such as consuming pets or strays.
- Desperation from Heroin Addiction: Heroin addicts, especially those living in extreme poverty, may consume non-traditional animals out of necessity. Chronic malnutrition and impaired judgment, combined with isolation from society, can drive addicts to make choices they wouldn’t otherwise consider.
Understanding the Cultural vs. Drug-Fueled Divide
It’s crucial to differentiate between cultural practices and behaviors driven by addiction when discussing the consumption of non-traditional animals. Respecting cultural practices while addressing the harmful impacts of substance abuse requires a nuanced understanding of these different contexts.
- Cultural Sensitivity: When discussing the consumption of non-traditional animals, especially in regions where this practice is accepted, it is important to approach the subject with cultural sensitivity. Condemning these practices without understanding their historical and social context can perpetuate stereotypes and breed intolerance.
- Addressing Addiction-Related Behaviors: Conversely, when the consumption of animals like dogs and cats is tied to addiction, the focus should be on treating the root causes of drug abuse rather than criminalizing individuals. Rehabilitation, mental health support, and access to food resources are critical in preventing desperate behaviors.
Ethical Considerations and Animal Welfare
Regardless of whether the consumption of non-traditional animals is driven by culture or desperation, the ethical treatment of animals is a key concern. The dog and cat meat industries have come under scrutiny for their inhumane treatment of animals, and organizations worldwide are working to promote animal welfare and ethical eating practices.
- Animal Rights in Cultural Contexts: While respecting cultural traditions, animal rights organizations are increasingly advocating for more humane practices within these industries. Campaigns to ban or reduce the consumption of dog and cat meat have gained traction, with a focus on reducing cruelty and promoting alternative food sources.
- Animal Cruelty and Drug Addiction: In cases of drug-induced behaviors, the animals involved often suffer from neglect or harm. Providing support for addicts and ensuring animals are removed from harmful environments can help mitigate this issue.
How to Approach the Issue Globally
Addressing the issue of non-traditional animal consumption, whether cultural or drug-fueled, requires a global approach that balances respect for cultural practices with the promotion of humane treatment for animals. Public health initiatives and cultural sensitivity training can help bridge the gap between different viewpoints while ensuring that animals and people alike are treated with dignity.
- Promoting Cultural Understanding: Efforts to educate the public on the cultural contexts of eating non-traditional animals can help reduce prejudice and promote more respectful global dialogues. Cultural exchange programs and educational campaigns can provide a more nuanced view of these practices.
- Addressing Substance Abuse: On the other hand, combatting the desperation and irrational behavior caused by addiction requires investments in mental health, addiction treatment, and public welfare systems. Providing addicts with support, housing, and access to food can reduce the likelihood of harmful or extreme behaviors.
Conclusion
While the consumption of non-traditional animals like dogs and cats may be culturally accepted in some regions, drug-induced behaviors that lead to similar actions must be understood in a different light. It’s important to address addiction-related behavior with compassion, focusing on rehabilitation and support rather than punishment. At the same time, promoting animal welfare and humane practices in regions where these animals are consumed can create a more ethical global community. By approaching these issues with respect for cultural diversity and a commitment to reducing harm, both animals and humans can benefit.
Related
Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?
Hemp and the New Senate Farm Bill
The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?
Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants
Find LivWell in Colorado
Find Verilife in Massachusetts
Find Verilife in Illinois
Find Verilife in New York
Ohio Non-Medical Cannabis is available at Verilife
Where quality meets savings: Independently owned Giving Tree offers fantastic deals
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse